Verition Fund Management
ANAB icon

Verition Fund Management’s AnaptysBio ANAB Stock Holding History

Verition Fund Management’s Portfolio ANAB Stock Details ANAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$506K Buy
+7,500
New +$455K ﹤0.01% 1628
2024
Q4 		– Sell
-22,036
Closed -$738K – 3228
2024
Q3 		$738K Buy
+22,036
New +$753K ﹤0.01% 2087
2024
Q2 		– Sell
-13,472
Closed -$303K – 2963
2024
Q1 		$303K Buy
+13,472
New +$319K ﹤0.01% 2294
2023
Q3 		– Sell
-24,380
Closed -$496K – 2327
2023
Q2 		$496K Buy
+24,380
New +$494K 0.01% 1245

Other funds holding ANAB

EC
EcoR1 Capital San Francisco, California $2.06B AUM 215.32% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return
S
Sanofi Paris, France $534M AUM 205.96% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Verition Fund Management's ANAB Position: Q2 2026 in Review

Verition Fund Management opened a new position in AnaptysBio (ANAB) in Q2 2026: 7,500 shares worth $506K. The stake represents ﹤0.01% of the portfolio and ranks #1628 among its holdings. This is a return to the name: Verition Fund Management previously reported a position in ANAB as recently as Q3 2024.

Verition Fund Management first reported a position in ANAB in Q2 2023 and has held it in 4 quarters since. The position peaked at $738K in Q3 2024. 213 funds tracked by Wall St. Rank hold ANAB as of Q2 2026.

  • Verition Fund Management held 7,500 shares of AnaptysBio worth $506K as of Q2 2026.
  • AnaptysBio was a new Verition Fund Management position in Q2 2026.
  • AnaptysBio made up ﹤0.01% of Verition Fund Management's portfolio in Q2 2026, its #1628 holding.
  • Verition Fund Management first reported a position in AnaptysBio in Q2 2023 and has held it in 4 quarters since.
  • Verition Fund Management's AnaptysBio position peaked at $738K in Q3 2024.
  • 213 funds tracked by Wall St. Rank held AnaptysBio as of Q2 2026.

Based on Verition Fund Management's 13F filing for Q2 2026, filed 14 Aug 2026.